The Cytokine Suppressor CIS in Giant Cell Pneumonitis
The Cytokine Suppressor CIS in Giant Cell Pneumonitis
批准号:
10133137
负责人:
Xuexian Yang
金额:
$37.88万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-04-01 至 2024-03-31
关键词:
AddressAllergicAlveolarAlveolar MacrophagesAnimal GeneticsAnimal ModelAntibodiesAntigen PresentationBiologyBronchoalveolar Lavage FluidCISH geneCell Differentiation processCellsCellular biologyCessation of lifeChronic DiseaseCobaltCollectionCore FacilityCytokine SignalingDataDevelopmentDiseaseEnvironmentEtiologyExposure toFamilyGeneticGiant CellsGoalsHealth SciencesHelper-Inducer T-LymphocyteHumanIgEImmuneImmunologicsKnowledgeLeadLungLung InflammationLung diseasesModernizationMolecularMusObstructionOccupational DiseasesOccupational ExposureParticulatePathogenesisPathologyPatientsPhysiologyPilot ProjectsPlayPulmonary InflammationRegulationRespiratory FailureRoleSTAT3 geneSTAT6 geneSerumSignal TransductionStat5 proteinT cell responseT-LymphocyteTh2 CellsTumor-infiltrating immune cellsVirusWorkcytokineeffective therapyhard metalimmunotoxicitymacrophagemembernovelnovel therapeuticspolarized cellpreventpublic health relevanceresponsetungsten carbide
中文摘要
项目摘要
巨细胞性肺炎是一组致死性慢性疾病,包括硬金属肺
疾病、病毒相关GCP和非硬金属、非感染性GCP。无论
在病因学方面,GCP的特征是存在肺泡巨噬细胞源性多核
巨细胞(MGCs)与其他免疫浸润物一起阻塞肺泡腔,
肺衰竭GCP的发病机制知之甚少,这主要是由于缺乏
适当的动物模型,并且没有有效的治疗方法,提出了关键的知识
间隙在这个提议中,我们将通过使用一种独特的动物来缩小这种知识差距的一个方面
我们最近开发的GCP模型,以研究导致
这种致命的疾病。硬金属(如钴)工人血清IgE水平升高,CD 4 +
辅助性T细胞(TH)2细胞依赖性抗体同种型,和硬金属GCP患者含有
支气管肺泡灌洗液(BALF)中的T细胞数量增加,提示
T细胞在GCP病理学中的潜在作用。然而,完全不清楚失调是如何
TH细胞的活化导致MGC的形成,从而导致GCP的发展。我们的长期目标是
剖析GCP发病机制的潜在机制;这些发现可能会导致新的
治疗选择这一建议的科学前提得到了我们的大力支持。
初步研究表明,CIS是细胞因子信号转导抑制因子(SOCS)家族的成员,
需要抑制GCP,这可能是通过T细胞依赖性方式;小鼠中的顺式缺陷
导致MGCs的形成和积累,并增加肺中TH细胞的数量
造成肺泡严重阻塞,甚至死亡。我们的核心假设是,
通过限制TH细胞反应抑制MGC形成,从而防止GCP。具体
目标:目标1。确定TH细胞-CIS在GCP发展中的内在作用。目标二。
阐明CIS在GCP中抑制作用的机制,特别是难
金属肺病
英文摘要
Project Summary
Giant cell pneumonitis (GCP) is a collection of fatal chronic diseases, including hard metal lung
disease, virus-associated GCP and non-hard metal, non-infectious GCP. Regardless of the
etiology, GCP is characterized by the presence of alveolar macrophage-derived multinucleate
giant cells (MGCs) that together with other immune infiltrates obstruct alveolar spaces and cause
lung failure. Little is known on the pathogenesis of GCP, which is largely due to lack of
appropriate animal models, and there is no effective treatment, presenting a critical knowledge
gap. In this proposal, we will close an aspect of this knowledge gap by using a unique animal
model of GCP we recently developed to investigate the immunological mechanisms that lead to
this fatal disease. Hard metal (such as cobalt) workers had elevated levels of serum IgE, a CD4+
T helper (TH) 2 cell-dependent antibody isotype, and patients with hard metal GCP contained
increased numbers of T cells in their bronchoalveolar lavage fluids (BALFs), implicating a
potential role of T cells in the pathology of GCP. However, it is entirely unclear how dysregulation
of TH cells causes MGC formation, resulting in the development of GCP. Our long-term goal is to
dissect the mechanisms underlying the pathogenesis of GCP; the discoveries may lead to novel
therapeutic options. The scientific premise of this proposal is strongly supported by our
preliminary studies that CIS, a member of the suppressor of the cytokine signaling (SOCS) family,
is required to suppress GCP, which is likely via a T cell-dependent manner; Cis-deficiency in mice
leads to formation and accumulation of MGCs with increased numbers of TH cells in the lungs
and causes severe obstruction of alveoli, leading to even death. Our central hypothesis is that CIS
inhibits MGC formation via restricting TH cell responses, therefore preventing GCP. The Specific
Aims are: Aim 1. Determine the TH cell-intrinsic role of CIS in the development of GCP. Aim 2.
Delineate the mechanism underlying the suppressive function of CIS in GCP, especially hard
metal lung disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Cytokine Suppressor CIS in Giant Cell Pneumonitis
-
批准号:10582702
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2020
-
负责人:Xuexian Yang
-
依托单位:
The Cytokine Suppressor CIS in Giant Cell Pneumonitis
-
批准号:10372043
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2020
-
负责人:Xuexian Yang
-
依托单位:
Regulation of T helper cell effector function
-
批准号:8894193
-
项目类别:
-
资助金额:$36.48万
-
财政年份:2014
-
负责人:Xuexian Yang
-
依托单位:
海外基金